• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

IFN-γ increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells

tetano

Editor, Senior Moderator
Mucosal Immunol. 2017 May 17. doi: 10.1038/mi.2017.41. [Epub ahead of print]
[h=1]IFN-γ increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells.[/h] Califano D[SUP]1[/SUP], Furuya Y[SUP]1[/SUP], Roberts S[SUP]1[/SUP], Avram D[SUP]1[/SUP], McKenzie ANJ[SUP]2[/SUP], Metzger DW[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Increased levels of interferon-γ (IFN-γ) are routinely observed in the respiratory tract following influenza virus infection, yet its potential role remains unclear. We now demonstrate that influenza-induced IFN-γ restricts protective innate lymphoid cell group II (ILC2) function in the lung following challenge with the pandemic H1N1 A/CA/04/2009 (CA04) influenza virus. Specifically, IFN-γ deficiency resulted in enhanced ILC2 activity, characterized by increased production of interleukin (IL)-5 and amphiregulin, and improved tissue integrity, yet no change in ILC2 numbers, viral load or clearance. We further found that IFN-γ-deficient mice, as well as wild-type animals treated with neutralizing anti-IFN-γ antibody, exhibited decreased susceptibility to lethal infection with H1N1 CA04 influenza virus, and moreover that survival was dependent on the presence of IL-5. The beneficial effects of IFN-γ neutralization were not observed in ILC2-deficient animals. These data support the novel concept that IFN-γ can have a detrimental role in the pathogenesis of influenza through a restriction in ILC2 activity. Thus, regulation of ILC2 activity is a potential target for post-infection therapy of influenza.Mucosal Immunology advance online publication 17 May 2017. doi:10.1038/mi.2017.41.


PMID: 28513592 DOI: 10.1038/mi.2017.41
 
Back
Top Bottom